eHealth (EHTH) Competitors $3.74 -0.16 (-4.10%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$3.86 +0.12 (+3.21%) As of 07/15/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EHTH vs. MMC, AJG, AON, BRO, CRD.B, HUIZ, OXBR, WTW, RYAN, and ERIEShould you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), Arthur J. Gallagher & Co. (AJG), AON (AON), Brown & Brown (BRO), Crawford & Company (CRD.B), Huize (HUIZ), Oxbridge Re (OXBR), Willis Towers Watson Public (WTW), Ryan Specialty (RYAN), and Erie Indemnity (ERIE). eHealth vs. Its Competitors Marsh & McLennan Companies Arthur J. Gallagher & Co. AON Brown & Brown Crawford & Company Huize Oxbridge Re Willis Towers Watson Public Ryan Specialty Erie Indemnity eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MMC) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation. Does the media refer more to EHTH or MMC? In the previous week, Marsh & McLennan Companies had 45 more articles in the media than eHealth. MarketBeat recorded 50 mentions for Marsh & McLennan Companies and 5 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.01 beat eHealth's score of 0.30 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment eHealth 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Marsh & McLennan Companies 27 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, EHTH or MMC? eHealth has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Marsh & McLennan Companies has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Is EHTH or MMC more profitable? Marsh & McLennan Companies has a net margin of 16.13% compared to eHealth's net margin of 4.14%. Marsh & McLennan Companies' return on equity of 32.19% beat eHealth's return on equity.Company Net Margins Return on Equity Return on Assets eHealth4.14% 2.16% 1.11% Marsh & McLennan Companies 16.13%32.19%8.39% Do institutionals and insiders hold more shares of EHTH or MMC? 79.5% of eHealth shares are held by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are held by institutional investors. 5.2% of eHealth shares are held by insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend EHTH or MMC? eHealth currently has a consensus target price of $6.75, suggesting a potential upside of 80.48%. Marsh & McLennan Companies has a consensus target price of $240.50, suggesting a potential upside of 14.05%. Given eHealth's stronger consensus rating and higher probable upside, research analysts clearly believe eHealth is more favorable than Marsh & McLennan Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eHealth 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Marsh & McLennan Companies 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21 Which has stronger valuation & earnings, EHTH or MMC? Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeHealth$532.41M0.21$10.06M-$0.98-3.82Marsh & McLennan Companies$24.46B4.25$4.06B$8.1625.84 SummaryMarsh & McLennan Companies beats eHealth on 12 of the 16 factors compared between the two stocks. Get eHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHTH vs. The Competition Export to ExcelMetriceHealthINS IndustryFinance SectorNASDAQ ExchangeMarket Cap$118.27M$26.79B$12.10B$9.29BDividend YieldN/A1.12%5.55%4.03%P/E Ratio-3.8237.0118.9919.58Price / Sales0.214.9426.3693.40Price / Cash180.3032.7221.6257.93Price / Book0.194.922.275.54Net Income$10.06M$835.86M$997.60M$257.73M7 Day Performance-10.10%0.83%-0.69%-0.08%1 Month Performance-10.95%4.34%2.92%8.09%1 Year Performance-20.59%-1.56%540.23%13.02% eHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHTHeHealth3.9311 of 5 stars$3.74-4.1%$6.75+80.5%-16.5%$118.27M$532.41M-3.821,773MMCMarsh & McLennan Companies4.4595 of 5 stars$213.04-0.9%$240.79+13.0%-3.5%$105.98B$24.46B26.1190,000Positive NewsUpcoming EarningsDividend IncreaseAJGArthur J. Gallagher & Co.4.0332 of 5 stars$315.76-0.7%$317.93+0.7%+13.9%$81.47B$11.40B45.7056,000Positive NewsAONAON4.2692 of 5 stars$353.19-0.4%$396.33+12.2%+18.6%$76.61B$15.70B30.0860,000Dividend AnnouncementBROBrown & Brown4.361 of 5 stars$107.74-0.9%$118.08+9.6%+14.0%$31.16B$4.81B30.0117,403Trending NewsCRD.BCrawford & Company4.3124 of 5 stars$10.32+0.1%N/A+20.9%$509.87M$1.34B17.2010,040HUIZHuize0.5615 of 5 stars$2.06+1.0%$2.30+11.7%-89.2%$20.53M$171.10M0.001,640OXBROxbridge Re2.4137 of 5 stars$1.95-9.7%$5.00+156.4%-13.0%$16.08M$550K0.003High Trading VolumeWTWWillis Towers Watson Public3.1455 of 5 stars$305.30-0.4%$355.20+16.3%+15.6%$30.40B$9.93B18.3248,900RYANRyan Specialty2.8243 of 5 stars$66.38-0.6%$75.25+13.4%+12.0%$17.53B$2.52B36.495,250Analyst ForecastERIEErie Indemnity1.4394 of 5 stars$341.31-1.6%N/A-8.7%$16.03B$3.80B29.056,801 Related Companies and Tools Related Companies MMC Alternatives AJG Alternatives AON Alternatives BRO Alternatives CRD.B Alternatives HUIZ Alternatives OXBR Alternatives WTW Alternatives RYAN Alternatives ERIE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EHTH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.